Cargando…
Phenytoin as a novel anti-vitiligo weapon
Vitiligo is a psychologically devastating clinical conundrum which affects approximately 1% of the general population. The exact cause of the illness is an enigma, but several hypotheses about its pathogenesis are advanced. The autoimmune hypothesis proposes an autoimmune attack against melanocytes....
Autor principal: | Namazi, MR |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308849/ https://www.ncbi.nlm.nih.gov/pubmed/16303054 http://dx.doi.org/10.1186/1740-2557-2-11 |
Ejemplares similares
-
Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy
por: Palermo, Belinda, et al.
Publicado: (2005) -
Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link
por: Namazi, MR
Publicado: (2009) -
Computational screening of molecular targets in Plasmodium for novel non resistant anti-malarial drugs
por: Singh, Neera, et al.
Publicado: (2009) -
Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
por: Luo, Fei, et al.
Publicado: (2016) -
Molecular docking based screening of novel designed chalcone series of compounds for their anti-cancer activity targeting EGFR kinase domain
por: Rao, Chennu Maruthi Malya Prasada, et al.
Publicado: (2015)